Business Context and Reporting Period
Company: Creative Medical Technology Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 11, 2017
Reporting Period: Event-based report for October 11, 2017.
Business Context: The Company is an emerging growth company incorporated in Nevada, focused on medical technology. This filing reports a specific corporate event regarding intellectual property.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is a current report regarding a specific event and does not contain financial statements or performance metrics.
Material Changes
Intellectual Property Development: On October 11, 2017, the Company announced the filing of a patent application. The application covers a treatment for stroke utilizing a combination of an FDA-approved drug and the patient's own bone marrow-derived stem cells.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The press release furnished as Exhibit 99.1 contains forward-looking statements based on information available as of the date of the report.
- Risk Factors: Actual results may differ materially from anticipated results due to various factors, including those discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2016, and subsequent SEC filings.
- Management Commentary: Management assumes no duty or obligation to update or revise forward-looking statements, though updates may be made via future reports or press releases.
Investor Verification Checklist
- Verify the status and scope of the patent application filed on October 11, 2017, for the stroke treatment method.
- Review the Company's Annual Report on Form 10-K for the year ended December 31, 2016, to understand the risk factors referenced in this filing.
- Confirm the specific FDA-approved drug intended for use in the combination therapy described in the press release (Exhibit 99.1).
- Assess the Company's current financial position and liquidity, as this filing does not provide updated financial data.